Press Release

The new service offering combines GNQ Insilico’s Causal AI Drug Assessment, Drug Simulation, and Digital Twin platforms with IBM’s consulting and hybrid cloud expertise. SAN JOSE, Calif.--(BUSINESS WIRE)--GNQ Insilico, Inc....

IB Acquisition Corp. Mon, March 16, 2026 at 1:45 PM EDT 12 min read   BOCA RATON, FL AND TORONTO, ONTARIO, March 16, 2026 (GLOBE NEWSWIRE) -- GNQ Insilico Inc....

GNQ Insilico's Quantum-enhanced and AI-powered Platform to Accelerate Development of MindLab's Novel Pain Management Therapy PLEASANTON, CA, UNITED STATES, October 30, 2025 /EINPresswire.com/ -- GNQ Insilico Inc., a pioneer in...

lti-Agentic AI Platform Powered by Proprietary Systems Biology Engine Delivers Personalized Therapy Optimization and Investment Risk Assessment PLEASANTON, CA, UNITED STATES, September 10, 2025 /EINPresswire.com/ -- GNQ Insilico Inc. (“GNQ”...

GNQ Insilico, Inc. (“GNQ” or “the Company”), a cutting-edge TechBio platform company, announced results from its proprietary Drug Assessment Platform. GNQ’s platform represents a breakthrough in computational drug development and...

GNQ Insilico, Inc. (“GNQ” or “the Company”), a TechBio platform company, demonstrated the advanced capabilities of its AI-powered Drug Assessment Platform in addressing critical treatment optimization challenges for patients with...

Sudhir Saxena, Chief Technology Officer of GNQ Insilico, Inc. (GNQ), was invited by Deloitte Consulting to present GNQ’s multi-omics approach to personalized medicine through AI-powered digital twins at the Quantum...

GNQ Insilico’s AI-Driven Digital Twins Platform Shows Promising Results in Simulating Effects of a Drug on Synthesized Digital Twins June 18, 2024 GNQ Insilico, Inc. (“GNQ” or “the Company”), a...

GNQ Insilico, Inc. (“GNQ” or “the Company”), a TechBio platform company, announced the successful development and validation of its AI-powered Drug Assessment Platform prototype for clomiphene citrate dose optimization. The...

SAN FRANCISCO, CALIFORNIA, USA, March 4, 2024 /EINPresswire.com/ — GNQ Insilico Inc. (“GNQ”), a company developing a generative artificial intelligence and quantum computing platform to assist life sciences companies in...